A New Class of Cancer Drug.
Kills Cancer Cells. Protects Normal Tissue.
Keeping America Safe
Protecting Civilians, First Responders and Our Military
from Nuclear Accidents and Terrorism.
Humanetics Corporation Presents at 2018 BIO CEO and Investor Conference
Humanetics Corporation Presents Data on Drug to Protect Cardiac Cells Against Toxicity From Space-Like Radiation
Vice Admiral Matthew L. Nathan, M.D., Former Surgeon General of the U.S. Navy, Joins Humanetics Medical advisory board
Humanetics Presents Data for Cancer Drug
Humanetics Receives New Grant from NASA
Humanetics Receives $3.8 Million Grant from Department of Defense
Humanetics Receives Patent for Cancer Drug
Humanetics to Present at Department of Defense Scientific Meeting